Domesco Medical Import Export JSCSTC:DMC 80 EBITDA Margin % is 13.76% as of Mar. 2026, which is 17% below its 10-year median of 16.62. GuruFocus rates STC:DMC with a GF Score™ of 80/100 and a GF Value™ of ₫73,467.60 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 952 Drug Manufacturers companies, Domesco Medical Import Export JSC ranks better than 50.21% on this metric.
Domesco Medical Import Export JSC (STC:DMC) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Domesco Medical Import Export JSC EBITDA Margin % Related Terms
Domesco Medical Import Export JSC EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Domesco Medical Import Export JSC EBITDA Margin % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Domesco Medical Import Export JSC's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Domesco Medical Import Export JSC EBITDA Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Domesco Medical Import Export JSC's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Domesco Medical Import Export JSC's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Domesco Medical Import Export JSC (STC:DMC) has a EBITDA Margin % of 13.76% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Domesco Medical Import Export JSC and its competitors. This is 17% below median its historical median of 16.62. Over the past decade, Domesco Medical Import Export JSC's EBITDA Margin % has ranged from 12.55 to 22.80. According to the industry distribution chart, Domesco Medical Import Export JSC ranks #474 out of 952 companies in the Drug Manufacturers industry, placing it in the top 49.8%.
Is Domesco Medical Import Export JSC's EBITDA Margin % too high?
Domesco Medical Import Export JSC's current EBITDA Margin % of 13.76% is 17% below median its 10-year median of 16.62. Over the past 10 years, this metric has ranged from a low of 12.55 to a high of 22.80. The Drug Manufacturers industry median EBITDA Margin % is 12.47. Domesco Medical Import Export JSC's value of 13.76% is 10.3% above this industry median. Based on the distribution chart, Domesco Medical Import Export JSC ranks #474 out of 952 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Domesco Medical Import Export JSC has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Domesco Medical Import Export JSC's EBITDA Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Domesco Medical Import Export JSC ranks #474 out of 952 companies for EBITDA Margin %. This puts Domesco Medical Import Export JSC in the upper half of its industry. The industry median EBITDA Margin % is 12.47. Domesco Medical Import Export JSC's value of 13.76% is 10.3% above this benchmark. Historically, Domesco Medical Import Export JSC's own EBITDA Margin % has ranged from 12.55 to 22.80 over the past decade. While the company's 10-year median is 16.62 vs. the industry median of 12.47, Domesco Medical Import Export JSC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.47, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Domesco Medical Import Export JSC's current EBITDA Margin % of 13.76% is 10.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Domesco Medical Import Export JSC and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Domesco Medical Import Export JSC's current EBITDA Margin % is 13.76%, which is 17% below median its own 10-year median of 16.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Domesco Medical Import Export JSC stock overvalued right now?
Based on GuruFocus' analysis, Domesco Medical Import Export JSC (STC:DMC) is currently considered Modestly Undervalued. The stock's GF Value™ is ₫73,467.60, compared to a current price of ₫57,600.00 — trading 21.6% below its estimated fair value. The current EBITDA Margin % is 13.76%, which is 17% below median its 10-year median of 16.62 and 10.3% above the Drug Manufacturers industry median of 12.47. Domesco Medical Import Export JSC's overall GF Score™ is 80/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Domesco Medical Import Export JSC (STC:DMC), the current EBITDA Margin % is 13.76% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Domesco Medical Import Export JSC (STC:DMC) Overvalued in 2026?
Based on GuruFocus' analysis, Domesco Medical Import Export JSC stock appears to be undervalued.
The current stock price of ₫57,600.00 is trading 21.6% below its estimated GF Value™ of ₫73,467.60.
GuruFocus considers Domesco Medical Import Export JSC to be Modestly Undervalued.
Key valuation signals for STC:DMC:
EBITDA Margin %: 13.76% (17% below median its 10-year median of 16.62)
GF Value™: ₫73,467.60 vs. price of ₫57,600.00 (21.6% below fair value)
Industry Position: 10.3% above the Drug Manufacturers median (#474 of 952)
No single metric tells the full story. See the STC:DMC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Domesco Medical Import Export JSC Business Description
Domesco Medical Import Export JSC is specialized in research, development, production, marketing and trading of Pharmaceuticals, medicines derived from Pharmaceutical materials, functional food, pure drinking water and medical beverages. It operates in import and export of medicines, medicine materials, food - functional foods, medical supplies, and medical equipment for medical examination and treatment for the whole people.
80GF Score
Get the complete analysis for STC:DMC
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STC:DMC has been successfully added to your 
